Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cypropofol vs propofol plus fentanyl for gastroenteroscopic sedation in high hypoxemia-risk adults
ChiCTR2300078575Phase 4Recruiting
- Sponsor
- Zhejiang Xiaoshan Hospital
- Start
- Dec 2023
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ciprofol (2 arms), sponsored by Zhejiang Xiaoshan Hospital. Primary endpoint: Incidence of SPO2 <92% between the start of sedation and the end of the procedure. Started Dec 2023; status: recruiting.
02
Drugs
ciprofol
Beyond the preview
Go deeper on ChiCTR2300078575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078575.